期刊文献+

双黄连口服液与雷尼替丁在口腔溃疡患者中的疗效对比观察 被引量:9

Comparison of the efficacy of Shuanghuanglian oral liquid and ranitidine in patients with oral ulcer
下载PDF
导出
摘要 目的观察对口腔溃疡患者使用雷尼替丁、双黄连口服液进行治疗的效果情况。方法随机抽取本院收治的口腔溃疡患者48例作为本文的观察对象,将其进行分组,对照组24例,观察组24例。对照组采用雷尼替丁对患者进行治疗,观察组则选用雷尼替丁联合双黄连口服液进行治疗,比较两组患者经治疗后的效果情况。结果对照组患者的总有效率较低于观察组患者的总有效率,不良反发生应率、疼痛评分高于观察组的不良反应发生率、疼痛评分,两组比较,观察组的效果更优,差异具有统计学意义(P<0.05)。结论采用两种药物联合对口腔溃疡患者治疗的效果显著,能够将其疼痛程度有效改善,加速溃疡创面的愈合时间,在临床上值得加大力度宣传、推广。 Objective To observe the effect of ranitidine and Shuanghuanglian oral liquid on patients with oral ulcer. Methods 48 patients with oral ulcers were randomly divided into two groups: control group (n=24) and observation group (n=24). In the control group, ranitidine was used to treat the patients. The observation group was treated with ranitidine combined with Shuanghuanglian oral liquid for the treatment, and the effect of the two groups after treatment was compared. Results The total effective rate of the patients in the control group was lower than that in the observation group, the adverse response rate and the pain score were higher than those in the observation group, the pain score, the two groups were better than the observation group, the difference was statistically significant (P<0.05). Conclusion The combination of two drugs on the treatment of oral ulcers in patients with significant effect, can effectively improve the degree of pain to accelerate the healing time of ulcer wounds, clinically worth increasing efforts to promote and promote.
作者 樊英艳 章福保 万真 Fan Yingyan;Zhang Fubao;Wan Zhen(Department of Stomatology,The First Hospital of Nanchang,Nanchang,Jiangxi,330008,China;Department of Nephrology,the First Hospital of Nanchang,Nanchang,Jiangxi,330008,China)
出处 《当代医学》 2019年第17期10-12,共3页 Contemporary Medicine
基金 江西省卫生计生委科技计划(20184017) 南昌市指导性科技计划项目洪科发计字(201839)
关键词 双黄连口服液 雷尼替丁 口腔溃疡 Shuanghuanglian oral liquid Ranitidine Oral ulcers
  • 相关文献

参考文献12

二级参考文献48

  • 1杨孝勇.联合使用双黄连口服液和雷尼替丁治疗口腔溃疡的疗效观察[J].当代医药论丛,2014,12(9):153-154. 被引量:15
  • 2May T, Goldstein DP, Berkowitz RS. Current chemotherapeutic management of patients with gestational trophoblastic neoplasia [ J]. Chemother Res Prac ,2011:206-256.
  • 3Ngan HY,Bender H,Benedet JL,et al. Gestational trophoblast- ic neoplasia, FIGO 2000 taging and classification [ J ]. Int J Gynaecol Obstet,2003,83 : 175-177.
  • 4Alazzam M,Tidy J,Hancock BW, et al. First line chemothera- py in low risk gestational trophoblastic neoplasia[ J]. Cochrane Database Syst Rev ,2009 .CD007102.
  • 5Osborne ILl, Filiaci V, Schink JC, et al. Phase III trial of week- ly methotrexate or pulsed dactinomycin for low-risk gestational trophoblastic neoplasia:a Gynecologic Oncology Group study [ J]. J Clin Onco1,2011,29 :825-831.
  • 6A1-Moheeriek A, AIDosari AM. Prevalence of oral lesions a- mong Saudi dental patients[ J]. Ann Saudi Med,2009,29(5 ) : 365 -368.
  • 7. Sonis ST, Elting LS, Keefe D, et al. Mucositis Study Section of the Multinational Association for Supportive Care in Cancer Perspectives on cancer therapy-induced mucosal injurd:patho- genesis, easurement, epidemiology, and consequences for pa- tients[ J]. Cancer,2004,100 : 1995-2025.
  • 8Scully C, Epstein J, Sonis S. Oral mucositis: a challenging complication of radiotherapy, chemotherapy, and radiochemo- therapy: part 1, pathogenesis and prophylaxis of mucositis [ J ]. Head Neck,2003,25:1057-1070.
  • 9Seckl MJ, Sebire NJ, Berkowitz RS. Gestational trophoblastic disease[ J]. Lancet,2010,376:717-729.
  • 10Kramer IR, Pindborg JJ,Bezroukov V, et al. World Health Or- ganization. Guide to epidemiology and diagnosis of oral muco- sal diseases and conditions [ J ]. Community Dent Oral Epide- miol, 1980,8 : 1-26.

共引文献54

同被引文献84

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部